Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Sofosbuvir-Based HCV Treatment in Maintenance Hemodialysis Patients: A Single-Center Study.

Transplantation proceedings - 1 Jan 2000

Gohel Kalpesh, Borasadia Pravin

Abstract excerpt

There is scant data on use of sofosbuvir containing direct-acting antiviral (DAA) regimens in maintenance hemodialysis (MHD) patients infected with hepatitis C virus (HCV). Recent data have focused on possible safe use of sofosbuvir in MHD patients. The aim of this study was to study the efficacy and safety of the sofosbuvir-based combination DAA in HCV-infected naive patients on MHD. Before starting treatment...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Benzimidazoles
Share to Drug Therapy, Combination
Share to Fluorenes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis C

Share to Liver Cirrhosis

Share to Renal Dialysis

Share to Sofosbuvir

Share to Sustained Virologic Response

Source

Identifiers

PMID: 32507712
DOI: 10.1016/j.transproceed.2020.02.136

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Sofosbuvir-Based HCV Treatment in Maintenance Hemodialysis Patients: A Single-Center Study.PMID 32507712Read ↗

Sofosbuvir-based Treatment for HCV: A Safe Option in Patients Undergoing Hemodialysis.Semantic proximity Read ↗

Pharmacokinetics, safety and efficacy of a full dose sofosbuvir-based regimen given daily in hemodialysis patients with chronic hepatitis C.Semantic proximity Read ↗

Treatment of chronic hepatitis C with sofosbuvir in a hemodialysis patient: a case report.Semantic proximity Read ↗

Use of Sofosbuvir-Based Treatment of Chronic Hepatitis C in Liver Transplant Recipients on Hemodialysis.Semantic proximity Read ↗

Efficacy and safety of sofosbuvir-based regimens in chronic hepatitis C patients on dialysis.Semantic proximity Read ↗

Sofosbuvir-based treatment is safe and effective in Indian hepatitis C patients on maintenance haemodialysis: A retrospective study.Semantic proximity Read ↗

Sofosbuvir and Velpatasvir combination is safe and effective in treating chronic hepatitis C in end-stage renal disease on maintenance haemodialysis.Semantic proximity Read ↗

Therapy of hepatitis C by direct-acting anti-virals: the end of HCV in dialysis population?Semantic proximity Read ↗

Sofosbuvir with NS5A inhibitors in hepatitis C virus infection with severe renal insufficiency.Semantic proximity Read ↗

Pegylated interferon alpha-2a for treatment of chronic HCV infection in hemodialysis patients: a single Saudi center experience.Semantic proximity Read ↗

Sofosbuvir-containing regimens are safe and effective in the treatment of HCV patients with moderate to severe renal impairment.Semantic proximity Read ↗

Effect and Safety of Daclatasvir-Asunaprevir Combination Therapy for Chronic Hepatitis C Virus Genotype 1b -Infected Patients on Hemodialysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.